BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
Go back to BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA| Bank of Commerce (NASDAQ: ONC) | Delayed: 342.08 +0.28 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $341.80 | 52 Week High | $0.35 | |||
| Open | $345.11 | 52 Week Low | $0.35 | |||
| Day High | $345.52 | P/E | N/A | |||
| Day Low | $341.22 | EPS | $0.00 | |||
| Volume | 7,031 | |||||
